Ramon Ortiz Carrasquillo, MD
Endocrinology, Diabetes & Metabolism · Manati, PRNPI 1639101926
Payments from drug & device makers
Across 2,170 payments — averaging $2786.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly Export S.A. Puerto Rico Branch$5.3M
- Novo Nordisk AS$558K
- Eli Lilly$160K
- Alnylam Pharmaceuticals Inc.$36K
- Novartis$18K
- AstraZeneca$850
- plus $3K from 13 others
Across 29 payments — averaging $5923.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$103K
- Eli Lilly Export S.A. Puerto Rico Branch$69K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly Export S.A. Puerto Rico Branch | 83 | $5,271,468 |
| Novo Nordisk AS | 1,767 | $557,522 |
| Eli Lilly | 118 | $159,942 |
| Alnylam Pharmaceuticals Inc. | 54 | $36,043 |
| Novartis | 1 | $18,050 |
| AstraZeneca | 48 | $850 |
| Amgen | 12 | $798 |
| Boehringer Ingelheim | 29 | $652 |
| Novo Nordisk | 20 | $433 |
| Sanofi-aventis U.S. LLC | 8 | $429 |
| Johnson & Johnson | 6 | $204 |
| Abbott | 8 | $182 |
| Edwards Lifesciences | 2 | $149 |
| Medtronic | 6 | $138 |
| Merck | 3 | $58 |
| Dexcom, Inc. | 2 | $45 |
| AbbVie | 1 | $25 |
| Lilly USA, LLC | 1 | $20 |
| Chiesi USA, Inc. | 1 | $19 |
How this compares
$6,047,026 in reported general payments places this provider in the 95th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.
See all endocrinology, diabetes & metabolism providers in Puerto Rico →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Manati
- Angel Comulada RiveraBayamon$8.9M
- Alex Gonzalez BossoloSan Juan$5.5M
- Martha GomezSan Juan$3.8M
- Paola Mansilla-LetelierBayamon$3.1M
- Altagracia Alcantara GonzalezBayamon$1M
- Myriam Allende-VigoHumacao$963K
- Jose Garcia MateoPonce$945K
- Wilfredo BravoCaguas$767K
- Michelle Mangual GarciaSan Juan$743K
- Juan OteroCaguas$452K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.